69 related articles for article (PubMed ID: 18787477)
1. Primary biliary cirrhosis, similar to that in human beings, in a male C57BL/6 mouse infected with Helicobacter pylori.
Goo MJ; Ki MR; Lee HR; Hong IH; Park JK; Yang HJ; Yuan DW; Hwang OK; Do SH; Yoo SE; Jeong KS
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1045-8. PubMed ID: 18787477
[TBL] [Abstract][Full Text] [Related]
2. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.
Floreani A; Biagini MR; Zappalà F; Farinati F; Plebani M; Rugge M; Surrenti C; Naccarato R
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):13-7. PubMed ID: 9265572
[TBL] [Abstract][Full Text] [Related]
3. The pathological effect of Helicobacter pylori infection on liver tissues in mice.
Huang Y; Tian XF; Fan XG; Fu CY; Zhu C
Clin Microbiol Infect; 2009 Sep; 15(9):843-9. PubMed ID: 19392901
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific.
Fox JG; Rogers AB; Ihrig M; Taylor NS; Whary MT; Dockray G; Varro A; Wang TC
Cancer Res; 2003 Mar; 63(5):942-50. PubMed ID: 12615707
[TBL] [Abstract][Full Text] [Related]
5. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis.
Boomkens SY; de Rave S; Pot RG; Egberink HF; Penning LC; Rothuizen J; Zondervan PE; Kusters JG
FEMS Immunol Med Microbiol; 2005 May; 44(2):221-5. PubMed ID: 15866219
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
7. [Helicobacter pylori infection and liver diseases].
Takuma Y
Gan To Kagaku Ryoho; 2011 Mar; 38(3):362-4. PubMed ID: 21403438
[TBL] [Abstract][Full Text] [Related]
8. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
9. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration.
Okada C; Akbar SM; Horiike N; Onji M
Liver Int; 2005 Jun; 25(3):595-603. PubMed ID: 15910497
[TBL] [Abstract][Full Text] [Related]
10. p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice.
Kuzushita N; Rogers AB; Monti NA; Whary MT; Park MJ; Aswad BI; Shirin H; Koff A; Eguchi H; Moss SF
Gastroenterology; 2005 Nov; 129(5):1544-56. PubMed ID: 16285954
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice.
Rogers AB; Taylor NS; Whary MT; Stefanich ED; Wang TC; Fox JG
Cancer Res; 2005 Dec; 65(23):10709-15. PubMed ID: 16322215
[TBL] [Abstract][Full Text] [Related]
12. [A two-year animal experimental study on the pathological effects of Helicobacter pylori on liver tissues].
Tian XF; Fan XG; Huang X; Fu CY; Dai H; Huang Y
Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):129-33. PubMed ID: 18304431
[TBL] [Abstract][Full Text] [Related]
13. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
14. [Campylobacter pylori in patients with liver cirrhosis of different etiologies].
Kataev SS; Lebedev SP; Golovanova OIu; Kon'kov MIu
Arkh Patol; 1990; 52(10):45-9. PubMed ID: 2281974
[TBL] [Abstract][Full Text] [Related]
15. Role of Helicobacter pylori infection on neuronal expression in the stomach and spinal cord of a murine model.
Li XB; Chen HM; Lu H; Zheng Q; Chen XY; Peng YS; Ge ZZ; Liu WZ
J Dig Dis; 2009 Nov; 10(4):286-92. PubMed ID: 19906107
[TBL] [Abstract][Full Text] [Related]
16. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY
Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin fails to lower serum lipid levels or inhibit gastric carcinogenesis in helicobacter pylori-infected rodent models.
Toyoda T; Tsukamoto T; Takasu S; Hirano N; Ban H; Shi L; Kumagai T; Tanaka T; Tatematsu M
Cancer Prev Res (Phila); 2009 Aug; 2(8):751-8. PubMed ID: 19622613
[TBL] [Abstract][Full Text] [Related]
18. SS1 Helicobacter pylori disrupts the paracellular barrier of the gastric mucosa and leads to neutrophilic gastritis in mice.
Suzuki K; Kokai Y; Sawada N; Takakuwa R; Kuwahara K; Isogai E; Isogai H; Mori M
Virchows Arch; 2002 Mar; 440(3):318-24. PubMed ID: 11889604
[TBL] [Abstract][Full Text] [Related]
19. Detection of Helicobacter in the liver of patients with chronic cholestatic liver diseases.
Nilsson HO; Castedal M; Olsson R; Wadström T
J Physiol Pharmacol; 1999 Dec; 50(5):875-82. PubMed ID: 10695566
[TBL] [Abstract][Full Text] [Related]
20. The effect of gender on Helicobacter felis-mediated gastritis, epithelial cell proliferation, and apoptosis in the mouse model.
Court M; Robinson PA; Dixon MF; Jeremy AH; Crabtree JE
J Pathol; 2003 Oct; 201(2):303-11. PubMed ID: 14517848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
